Commonwealth Equity Services
MGNX icon

Commonwealth Equity Services’s MacroGenics MGNX Stock Holding History

Commonwealth Equity Services’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,950
Closed -$64K – 3891
2023
Q2 		$64K Hold
11,950
– – ﹤0.01% 3632
2023
Q1 		$85 Buy
11,950
+400
+3% +$2.41K ﹤0.01% 3518
2022
Q4 		$77K Buy
+11,550
New +$63.3K ﹤0.01% 3457
2021
Q3 		– Sell
-7,519
Closed -$201K – 3634
2021
Q2 		$201K Buy
7,519
+1,000
+15% +$29.3K ﹤0.01% 3262
2021
Q1 		$207K Buy
+6,519
New +$158K ﹤0.01% 3094

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Commonwealth Equity Services's MGNX Position: Q3 2023 in Review

Commonwealth Equity Services sold out of MacroGenics (MGNX) in Q3 2023, closing a stake of 11,950 shares — an estimated $64K sold.

Commonwealth Equity Services first reported a position in MGNX in Q1 2021 and held it in 5 quarters. The position peaked at $207K in Q1 2021. 127 funds tracked by Wall St. Rank hold MGNX as of Q3 2023.

  • Commonwealth Equity Services reported no remaining MacroGenics position as of Q3 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 11,950 MacroGenics shares in Q3 2023, an estimated $64K.
  • Commonwealth Equity Services first reported a position in MacroGenics in Q1 2021 and held it in 5 quarters.
  • Commonwealth Equity Services's MacroGenics position peaked at $207K in Q1 2021.
  • 127 funds tracked by Wall St. Rank held MacroGenics as of Q3 2023.

Based on Commonwealth Equity Services's 13F filing for Q3 2023, filed 23 Oct 2023.